aap Implantate AG

As of June 30, 2019, aap Implantate AG has 3.48M shares outstanding.

As of June 30, 2019, aap Implantate AG maintains a current ratio of 4.13, meaning it holds 4.1x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2019, aap Implantate AG posted a negative return on equity (ROE) of -23.25, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -18.90, reflecting losses generated across the asset base. The company generates approximately 77,394.87 in revenue per employee across its workforce of 146.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.07 indicates how many times aap Implantate AG sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2019, aap Implantate AG recorded 259,000.00 in income tax expense. The company reported a pretax loss of -8.21M and -8.47M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, aap Implantate AG's stock has declined approximately 3.33% over the past 52 weeks. The 50-day moving average sits at 1.60, while the 200-day moving average is 1.64.

Over the twelve months ended June 30, 2019, aap Implantate AG generated 11.32M in revenue and converted that into -8.47M in net income, yielding earnings per share of -2.60. EBITDA reached -6.47M, while operating income came in at -8.53M.

These figures are as of June 30, 2019. Total book value stands at 33.93M, with working capital of 14.81M providing operational flexibility.

aap Implantate AG produced -5.43M in operating cash flow over the twelve months ended June 30, 2019. After subtracting -2.39M in capital expenditures, free cash flow totaled -7.82M - equivalent to -2.41 per share.

Over the twelve months ended June 30, 2019, aap Implantate AG posted a gross margin of 94.75, reflecting its pricing power and cost economics. The operating margin of -75.34 and net profit margin of -74.82 provide insight into operational efficiency.

aap Implantate AG's most recent stock split took place on September 30, 2021 with a 835:906 split ratio.